JY
OPTR

Jeff Yass’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Jeff Yass’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-38,700
Closed -$488K – 9753
2013
Q3 		$488K Sell
38,700
-54,500
-58% -$722K ﹤0.01% 6466
2013
Q2 		$1.35M Buy
+93,200
New +$1.36M ﹤0.01% 4516

Jeff Yass's OPTR Position: Q4 2013 in Review

Jeff Yass sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 566,565 shares — an estimated $7.14M sold.

Jeff Yass first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $7.14M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Jeff Yass reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Jeff Yass sold 566,565 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $7.14M.
  • Jeff Yass first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Jeff Yass's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $7.14M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Susquehanna International Group's 13F filing for Q4 2013, filed 13 Feb 2014.